TEJAM · Novel Antimicrobials from Endophytes of Northern Medicinal Plants
FP7 — People (Marie Curie Actions)
- Duration
- 2008-04-01 → 2010-03-31
- EU contribution
- €173,641
- Participants
- 1
- Scheme
- MC-IIF
Lines connect the coordinator with its partners.
Results in brief
Periodic Report Summary - TEJAM (Novel antimicrobials from endophytes of northern medicinal plants)
Antibacterial resistance is spreading globally at an alarming rate and continues to increase. New potent antimicrobials are therefore constantly needed. Many of the pharmaceutical companies during the past decades focussed mainly on the development of antibiotics that offered variations on existing themes; therefore the flow of truly new compounds acting on new targets was diminished, whereas the bacterial resistance continued to spread. Even genomics did not provide the knowledge-based compounds that were expected, and now a new promise is being looked for in natural products from endophytic fungi. During the TEJAM project new, high-throughput methods for screening antibacterial and antioxidant activities were tested and used for isolating antibacterial and antioxidant endophytic fungi. Fungal endophytes were isolated from two shrubs i.e. rhododendron tomentosum (RT) and calluna vulgaris (CV). All endophytic fungi were grown in two different media, enriched (MEB) and depleted (DM), and screened for antibacterial and antioxidant activities. As a result, 15 % of endophytic fungi of RT produced antibacterials and 14 % antioxidants; in total, 29 % of the isolates had biological activity. In contrast, 8 % of endophytes of CV produced antibacterials and 16 % antioxidants. The majority of antibacterial compounds were produced in DM media and antioxidants in MEB media. Therefore, it was advisable to test various alternative media for the production of antibacterials and antioxidants. The world's biodiversity is overall underexplored. The classical microbiology was based on the study of cultured organisms, which represented an extremely low percentage of all microbial diversity. Various approaches for studying the uncultured microbes were developed in the biotechnology era, enabling scientists to access these previously untapped biological resources. In this study, fungal endophytes that were morphologically distinct were selected for identification. Eighteen and 20 isolates of endophytic fungi were identified from rhododendron tomentosum (RT) and calluna vulgaris (CV), respectively, by sequencing the internal transcribed spacer (ITS) region (ITS1-5.8S-ITS2). The unculturable endophytic fungi were identified by polymerase chain reaction (PCR) amplification, cloning and sequencing of the ITS region. Eighteen clones from CV and 11 clones from RT were sequenced and searched through the Genbank database using the basic local alignment search tool (BLAST). Moreover, all sequences were submitted to the Genbank and accession numbers were obtained. In addition, TEJAM utilised and optimised state of the art methods, such as metagenomics on endophyte research to identify an antibacterial protein from empetrum nigrum L. The library was screened to select antibacterial clones using staphylococcus aureus as a target organism by the double agar layer method. One unique clone exhibiting antibacterial activity was selected from the metagenomic library. Based on the deduced amino acid similarity, the metagenomic gene encoded a protein without any known signal peptide, having three conserved pentatricopeptide motifs and displaying from 26 to 28 % identity to other hypothetical proteins. The predicted gene was expressed in escherichia coli and the protein was digested with trypsin. The trypsin digest was active against staphylococcus aureus. The active peptide was in the process of being identified by the time of this reporting period.
Data: CORDIS, © European Union
Project objective
Antibacterial resistance is spreading globally at an alarming rate and continues to increase. New potent antimicrobials are therefore continually needed. In recent years, new antibacterial compounds have mainly been additions to the existing classes of drugs and truly new structures have rarely been developed. The derivatives of existing drugs however raise bacterial resistance much faster than completely new compounds. Pharmaceutical industry has little interest in developing new structures due to high investment and low profit expectancy. To overcome the chronic problem of antibiotic resistance, totally new compounds and approaches are required, involving collaboration of researchers from various disciplines, as well as high societal investments. The TEJAM project involves the highly experienced Fellow, Dr. M.V. Tejesvi (University of Mysore, India) and Departments of Biology and Chemistry at the University of Oulu, Finland. Both participants (Fellow and Host Institution) have a similar history of screening for bioactive compounds from endophytes, internal plant microbes. The project aims at i) discovery of totally new antimicrobial, as well as antioxidant and antihypertensive compounds from one of the richest untapped natural sources, endophytes, ii) development of new methods for efficient drug discovery from endophytes and iii) increased international collaboration in the area of discovery of novel bioactive compounds. During the TEJAM project, new high-throughput methods will be tested and used for screening and developing new leads for the pharmaceutical industry. TEJAM is utilizing and optimizing state-of-the-art methods, such as HT robotic screening and metagenomics, on the endophyte research. The project is closely linked to two consortia focused on research of new antimicrobials and will potentially strengthen the basis for business and pharmaceutical industry in Europe.
Original text from CORDIS.
Participants
- OULUN YLIOPISTO · OuluCoordinatorFinland
Links
Data: CORDIS, © European Union
